Developing the Next Generation Of Immunotherapy To Combat Cancer
Targeting ENPP1: The Only Known Checkpoint In Innate Immunity
Activation of the cGAS-STING pathway begins by recognition of cytoplasmic dsDNA by cGAS which then generates the natural ligand of STING, 2’3’ cGAMP
ENPP1 negatively regulates this pathway by breaking down 2’3’ cGAMP into AMP and GMP
AMP can be converted by CD73 into Adenosine, a key immune suppressive molecule in the tumor microenvironment
ENPP1 is highly upregulated as tumors becomes metastatic
High levels of ENPP1 have been correlated with:
Reduced immune infiltration
Increased metastasis
Tumor resistance to chemotherapy and adaptive immunotherapies